Treatment of atherosclerotic disease

Details for Australian Patent Application No. 2007224175 (hide)

Owner ActivBiotics, Inc.

Inventors Sternlicht, Andrew

Agent Griffith Hack

Pub. Number AU-A-2007224175

PCT Pub. Number WO2007/103149

Priority 60/779,274 03.03.06 US

Filing date 1 March 2007

Wipo publication date 13 September 2007

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103149 Priority application(s): WO2007/103149

27 November 2008 Assignment before Grant

  ActivBiotics, Inc. The application has been assigned to ActivBiotics Pharma LLC Assignments before Grant, Section 113

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007224178-Dry powder inhaler with aeroelastic dispersion mechanism

2007224172-Truncated proteins as cancer markers